Search Results - "Tanioka, H."

Heat shock protein 90 (HSP90) inhibitor as a candidate treatment option for gastrointestinal stromal tumor with acquired resistance for conventional receptor tyrosine kinase inhibitors by Yamamura, M., Yamauchi, A., Katase, N., Katata, Y., Tanioka, H., Okawaki, M., Nagasaka, T., Yamaguchi, Y.

Get full text

Poor prognosis of hypermutant colorectal cancer with KRAS mutations: A retrospective analysis of 1,052 Japanese colorectal cancer patients without treatment of immuno-checkpoint inhibitors by Nagasaka, T., Tanioka, H., Nyuya, A., Katata, Y., Okawaki, M., Yamamura, M., Kawai, T., Yasui, K., Toshima, T., Mori, Y., Umeda, Y., Tsuruta, A., Ueno, T., Yamaguchi, Y.

Get full text

Relationship between peripheral neuropathy and effectiveness in second-line chemotherapy for unresectable advanced gastric cancer: a prospective, observational, multicenter study protocol by Tanioka, H., Nagasaka, T., Uno, F., Inoue, M., Okita, H., Katata, Y., Kanzaki, H., Kuramochi, H., Satake, H., Shindo, Y., Doi, A., Nasu, J., Yamashita, H., Yamaguchi, Y.

Get full text

Efficacy of ramucirumab in combination with second-line or salvage-line FOLFIRI in patients with metastatic colorectal cancer by Katata, Y., Nagasaka, T., Tanioka, H., Nyuya, A., Toshima, T., Mori, Y., Shigeyasu, K., Okawaki, M., Yamamura, M., Tsuruta, A., Ueno, T., Yamaguchi, Y.

Get full text

Incidence of catheter-related thrombosis in patients with long-term indwelling central venous catheter who received chemotherapies for unresectable advanced digestive cancers by Tanioka, H., Asano, M., Kawasaki, K., Yoshida, R., Waki, N., Uno, F., Ishizaki, M., Yamashita, K., Morishita, Y., Katata, Y., Nagasaka, T.

Get full text

Distinct clinico-pathological features of hypermutant colorectal cancers with POLE pathogenic mutations, Lynch syndrome and sporadic MSI analyzed over 1,000 colorectal cancer patients by Nagasaka, T, Nyuya, A, Tanioka, H, Katata, Y, Yokota, M, Taniguchi, F, Kawai, T, Mori, Y, Shigeyasu, K, Okawaki, M, Yamamura, M, Umeda, Y, Tsuruta, A, Ueno, T, Yamaguchi, Y

Get full text

Beneficial effects of leptin on glycaemic and lipid control in a mouse model of type 2 diabetes with increased adiposity induced by streptozotocin and a high-fat diet by Kusakabe, T, Tanioka, H, Ebihara, K, Hirata, M, Miyamoto, L, Miyanaga, F, Hige, H, Aotani, D, Fujisawa, T, Masuzaki, H, Hosoda, K, Nakao, K

“…Aims/hypothesis We have previously demonstrated the therapeutic usefulness of leptin in lipoatrophic diabetes and insulin-deficient diabetes in mouse models…”
Get full text

Chemotherapy after nivolumab for advanced gastric cancer (REVIVE): a prospective observational study by Narita, Y, Matsushima, T, Sakamoto, Y, Matsuoka, H, Tanioka, H, Kawakami, T, Shoji, H, Mizukami, T, Izawa, N, Nishina, T, Yamamoto, Y, Mitani, S, Nakamura, M, Misumi, T, Muro, K

“…Nivolumab therapy is a standard-of-care treatment for heavily pretreated patients with advanced gastric cancer (AGC). Previous studies have reported…”
Get full text

A phase I/II study of panitumumab combined with TAS-102 in patients (pts) with RAS wild-type (wt) metastatic colorectal cancer (mCRC) refractory to standard chemotherapy: APOLLON study by Yamazaki, K., Yasui, H., Yamaguchi, K., Kagawa, Y., Kuboki, Y., Yoshino, T., Gamoh, M., Komatsu, Y., Satake, H., Goto, M., Tanioka, H., Oki, E., Kotaka, M., Makiyama, A., Denda, T., Soeda, J., Shibya, K., Iwata, M., Oba, K., Kato, T.

Get full text

P-054The clinical predictor of antitumor efficacy of cetuximab based regimen in first-line therapy to unresectable metastatic colorectal cancer by Tanioka, H, Nagasaka, T, Asano, M, Ikeda, K, Yoshida, R, Waki, N, Ishizaki, M, Yamashita, K

Get full text

P-053Updated analysis of induction & maintenance adjuvant chemotherapy with 3-month oxaliplatin-based regimen followed by 3 months capecitabine in patients with stage III and high-risk stage II colorectal cancer :(JSWOG C2) by Tanioka, H, Yamashita, K, Tsuruta, A, Tsuji, A, Nagasaka, T, Okumura, H, Oka, Y, Inukai, M, Yamakawa, T, Yamatsuji, T, Yoshimitsu, M, Toyota, K, Yamano, T, Okajima, M

Get full text

Basophils in the giant papillae of chronic allergic keratoconjunctivitis by Matsuda, A, Ebihara, N, Yokoi, N, Okayama, Y, Watanabe, Y, Kawasaki, S, Tanioka, H, Walls, A F, Hamuro, J, Kinoshita, S, Murakami, A

“…The essential role of basophils as an initiator of chronic allergic reaction has been elucidated in mouse models. The aim of this present study was to analyse…”
Get more information

Telomerase components as a diagnostic tool in human oral lesions by Sumida, Tomoki, Hamakawa, Hiroyuki, Sogawa, Kenichi, Sugita, Atsuro, Tanioka, Hiroaki, Ueda, Norifumi

“…Telomerase activity is considered to be a diagnostic marker of malignancy since most malignant cells express this activity and most somatic cells do not…”
Get full text

Contrast-enhanced MR images in patients with meningioma: importance of enhancement of the dura adjacent to the tumor by Aoki, S, Sasaki, Y, Machida, T, Tanioka, H

“…Linear enhancement (flare sign) along the dura mater that was continuous with or emanated from the dural margin of meningiomas was frequently observed on…”
Get full text

Detection of human herpesvirus 6 and human herpesvirus 7 in the submandibular gland, parotid gland, and lip salivary gland by PCR by Sada, E, Yasukawa, M, Ito, C, Takeda, A, Shiosaka, T, Tanioka, H, Fujita, S

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

1585P The impact of platinum-induced peripheral neuropathy (PN) in first-line treatment on PN and efficacy in second-line paclitaxel (PTX)-based chemotherapy for unresectable advanced gastric cancer (AGC): A prospective observational multicenter study - IVY study by Kono, Y., Tanioka, H., Kito, Y., Ando, T., Negoro, Y., Abe, T., Kuramochi, H., Boku, S., Mannami, T., Nasu, J., Inoue, M., Nakamura, M., Okita, Y., Shindo, Y., Maeda, T., Shinohara, Y., Yano, S., Okawaki, M., Nagasaka, T.

Get full text

Treatment of mandibular malignant fibrous histiocytoma during pregnancy by Otsuka, Koji, Hamakawa, Hiroyuki, Sumida, Tomoki, Tanioka, Hiroaki

Get full text

1622PHeat shock protein 90 (HSP90) inhibitor as a candidate treatment option for gastrointestinal stromal tumor with acquired resistance for conventional receptor tyrosine kinase inhibitors by Yamamura, M, Yamauchi, A, Katase, N, Katata, Y, Tanioka, H, Okawaki, M, Nagasaka, T, Yamaguchi, Y

Get full text

P-61 Impacts of salvage chemotherapy after nivolumab therapy (NIVO): A REVIVE substudy by Matsuoka, H., Narita, Y., Misumi, T., Sakamoto, Y., Kawakami, T., Tanioka, H., Matsushima, T., Miwa, H., Shoji, H., Ishiguro, A., Fushida, S., Miura, K., Yamada, T., Shinozaki, K., Mizukami, T., Moriwaki, T., Mitani, S., Nakamura, M., Muro, K., Nishina, T.

Get full text

Indication for epidural morphine for the relief of intractable pain in advanced oral cancer: report of four cases by Kayahara, H., Hamakawa, H., Fukuzumi, M., Tanioka, H.

“…It can be difficult to manage the pain of advanced oral cancer. We present four patients in whom epidural morphine was used for intractable pain at primary or…”
Get full text